文献速递分子诊断临床微生物临床免疫

直肠与口咽沙眼衣原体及淋病奈瑟菌感染核酸检测的多中心比较

Multicenter Comparison of Nucleic Acid Amplification Tests for the Diagnosis of Rectal and Oropharyngeal Chlamydia trachomatis and Neisseria gonorrhoeae Infections.
PubMed 文献 · J Clin Microbiol · 2021-11-03

研究在2018年5月至2019年8月招募1108名女性、1256名男性和26名跨性别者,每人提供3份肛门和3份口咽拭子并分别混合。比较三种核酸检测试验与复合结果及相互间的性能,结果显示肛门和口咽衣原体阳性率分别为5.9%和1.2%,淋病为4.2%和4.1%,各试验特异性均≥98.9%。

要点

  • 肛门衣原体敏感性81.0-95.1%,口咽82.8-100%。
  • 肛门淋病敏感性85.9-99.0%,口咽74.0-100%。
  • 所有试验、病原体和样本类型的特异性估计均≥98.9%。

核心结论

  • 尽管各试验敏感性存在异质性,这些核酸检测试验检测生殖器外感染的能力优于培养。

研究设计与样本

  • 多中心研究,2018年5月至2019年8月招募1108名女性、1256名男性和26名跨性别者,每人提供3份肛门和3份口咽拭子并分别混合。

主要发现

  • 肛门和口咽衣原体阳性率分别为5.9%和1.2%,淋病阳性率分别为4.2%和4.1%。
  • 肛门和口咽衣原体敏感性分别为81.0-95.1%和82.8-100%。
  • 肛门和口咽淋病敏感性分别为85.9-99.0%和74.0-100%。
  • 所有试验、病原体和样本类型的特异性估计均≥98.9%。

临床怎么用

  • 这些核酸检测试验可用于检测肛门和口咽的沙眼衣原体及淋病奈瑟菌感染。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Research using nucleic acid amplification tests (NAATs) have repeatedly found rectal and oropharyngeal infections with Chlamydia trachomatis and Neisseria gonorrhoeae to be common and potentially more difficult to treat than genital infections. Unfortunately, public health and patient care efforts have been hampered by the lack of FDA-cleared NAATs with claims for anorectal or oropharyngeal samples. At the time of the initiation of this study, no commercially available assays had these claims. We formed a novel partnership among academic institutions and diagnostic manufacturers to address this public health need. From May 2018 through August 2019, we recruited 1108 women, 1256 men, and 26 transgender persons each of whom provided 3 anal and 3 oropharyngeal swab specimens. The 3 anal swabs were pooled into a single transport tube as were the 3 oropharyngeal swabs. The performance of each of three study assays was estimated by comparison to the composite result and relative to one another. Percent positivity for chlamydia was 5.9 and 1.2% from anal and oropharyngeal specimens, respectively, compared to 4.2 and 4.1% for gonorrhea. Sensitivity for chlamydia detection ranged from 81.0 to 95.1% and 82.8 to 100% for anal and oropharyngeal specimens, respectively. Gonorrhea sensitivity ranged from 85.9 to 99.0% and 74.0 to 100% for anal and oropharyngeal samples, respectively. Specificity estimates were ≥ 98.9% for all assays, organisms, and sample types. Although there was heterogeneity between sensitivity estimates, these assays offer better ability to detect extragenital infections than culture and potential solutions for providing appropriate sexual health care for populations in which these infections are of concern.

来源:J Clin Microbiol,查看原文。版权归原作者所有。

引用

  1. Van Der Pol B, Chernesky M, Gaydos CA, et al. Multicenter Comparison of Nucleic Acid Amplification Tests for the Diagnosis of Rectal and Oropharyngeal Chlamydia trachomatis and Neisseria gonorrhoeae Infections. J Clin Microbiol. 2021. PMID: 34731020. doi:10.1128/JCM.01363-21

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。